[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ZA938952B - Infectious bursal disease vaccine - Google Patents

Infectious bursal disease vaccine

Info

Publication number
ZA938952B
ZA938952B ZA938952A ZA938952A ZA938952B ZA 938952 B ZA938952 B ZA 938952B ZA 938952 A ZA938952 A ZA 938952A ZA 938952 A ZA938952 A ZA 938952A ZA 938952 B ZA938952 B ZA 938952B
Authority
ZA
South Africa
Prior art keywords
bursal disease
infectious bursal
under
immunizing amount
effective immunizing
Prior art date
Application number
ZA938952A
Other languages
English (en)
Inventor
Bezalel Gutter
Original Assignee
Abic Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abic Ltd filed Critical Abic Ltd
Publication of ZA938952B publication Critical patent/ZA938952B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/544—Mucosal route to the airways
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18111—Avulavirus, e.g. Newcastle disease virus
    • C12N2760/18134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA938952A 1992-12-01 1993-11-30 Infectious bursal disease vaccine ZA938952B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL10393992A IL103939A (en) 1992-12-01 1992-12-01 An anti-DBI vaccine in birds containing attenuated live DBI virus

Publications (1)

Publication Number Publication Date
ZA938952B true ZA938952B (en) 1994-08-02

Family

ID=11064287

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA938952A ZA938952B (en) 1992-12-01 1993-11-30 Infectious bursal disease vaccine

Country Status (14)

Country Link
US (1) US5804195A (xx)
EP (1) EP0600723B1 (xx)
KR (1) KR0127116B1 (xx)
CN (1) CN1072962C (xx)
AT (1) ATE191644T1 (xx)
BR (1) BR9304911A (xx)
CZ (1) CZ282443B6 (xx)
DE (1) DE69328341T2 (xx)
ES (1) ES2147557T3 (xx)
HU (1) HU214737B (xx)
IL (1) IL103939A (xx)
PL (1) PL177386B1 (xx)
RU (1) RU2126268C1 (xx)
ZA (1) ZA938952B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0861665A1 (en) * 1997-02-03 1998-09-02 Dimminaco Ag/Sa/Ltd. Infectious bursitis vaccine
KR20000056034A (ko) * 1999-02-12 2000-09-15 에릭 발리베 스테이터코일의 와인딩장치
WO2005049077A2 (en) * 2003-11-17 2005-06-02 Regents Of The University Of Minnesota Avian vaccine effective against infectious bursal disease virus
AU2005222604B2 (en) 2004-03-12 2011-08-11 Zoetis Services Llc Infectious Bursal Disease Virus antigenic isolates and vaccines
ES2386272T3 (es) 2004-09-09 2012-08-16 Novartis Vaccines And Diagnostics Gmbh Reducción de riesgos iatrogénicos potenciales asociados a las vacunas antigripales
CN103143007B (zh) * 2013-02-27 2014-10-01 哈药集团生物疫苗有限公司 一种利用传代鸡胚成纤维细胞制备传染性法氏囊病毒活疫苗的方法
KR101511712B1 (ko) * 2013-04-03 2015-04-13 주식회사 카브 신규 전염성 ｆ낭병 바이러스 ｉｂｄ ｋ7주 및 이를 이용한 전염성 ｆ낭병 백신
WO2016020730A1 (es) * 2014-08-08 2016-02-11 Laboratorio Avi-Mex, S.A. De C.V. Vacuna en vector recombinante de adenovirus aviar serotipo 9
EP3334289B1 (en) 2015-08-14 2019-10-02 Clearh2o, Inc. High throughput process for delivering semi-firm gel for poultry

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3584055A (en) * 1966-06-18 1971-06-08 Basf Ag Production of butyraldehydes and butanols with a high proportion of linear compounds
US4530831A (en) * 1982-11-02 1985-07-23 Akzo N.V. Infectious Bursal Disease vaccine
US4824668A (en) * 1987-03-09 1989-04-25 Sterwin Laboratories Inc. Attenuated infectious bursal disease virus strain and vaccine therefrom
US5064646A (en) * 1988-08-02 1991-11-12 The University Of Maryland Novel infectious bursal disease virus
US5192539A (en) * 1988-07-21 1993-03-09 Akzo N.V. Infectious bursal disease virus production in continuous cell lines
NZ235474A (en) * 1989-10-18 1992-12-23 Univ Maryland Virus capable of inducing infectious bursal disease; assay and vaccine

Also Published As

Publication number Publication date
KR0127116B1 (ko) 1998-04-01
EP0600723A3 (en) 1995-01-11
RU2126268C1 (ru) 1999-02-20
CN1113158A (zh) 1995-12-13
DE69328341D1 (de) 2000-05-18
IL103939A0 (en) 1993-05-13
ES2147557T3 (es) 2000-09-16
CZ260593A3 (en) 1994-06-15
IL103939A (en) 1996-09-12
KR940013536A (ko) 1994-07-15
CN1072962C (zh) 2001-10-17
CZ282443B6 (cs) 1997-07-16
PL177386B1 (pl) 1999-11-30
HU9303369D0 (en) 1994-03-28
HU214737B (hu) 2000-03-28
PL301253A1 (en) 1994-06-13
US5804195A (en) 1998-09-08
EP0600723B1 (en) 2000-04-12
ATE191644T1 (de) 2000-04-15
DE69328341T2 (de) 2000-12-14
HUT67324A (en) 1995-03-28
EP0600723A2 (en) 1994-06-08
BR9304911A (pt) 1994-06-14

Similar Documents

Publication Publication Date Title
KR100245654B1 (en) Attenuated, genetically engineered pseudorabies virus s-prv-155 and uses thereof
ES2152292T3 (es) Vacuna para aves de corral que contiene el virus de la bronquitis infecciosa 4/91.
IL103939A0 (en) Infectious bursal disease vaccine
CA2134835A1 (en) Live in ovo vaccine
HU9201746D0 (en) Recombinant avipox virus, the virus infected cell cultivation and the vaccine resulted from it for poultry vaccination
IE780360L (en) Vaccine against "egg drop disease".
EP0626008A4 (en) Vaccine containing acemannan as an adjuvant.
CA2181862A1 (en) Mild newcastle disease virus vaccine
YU65102A (sh) In ovo zaštita protiv infektivnog bronhitisa
US5149530A (en) Live newcastle disease virus vaccines
Peleg et al. Immunization of chickens with live Newcastle disease vaccine adjuvanted with oil
Ezeokoli et al. Immunosuppression and histopathological changes in the bursa of Fabricius associated with infectious bursal disease vaccination in chicken
Sharma Role of tumor antigen in vaccine protection in Marek’s disease
RU2761566C1 (ru) Вакцина иммунокомплексная против инфекционной бурсальной болезни птиц из штамма "ВНИВИП"
US5565202A (en) Low enhancement serotype 2 vaccine for marek's disease
WO1999037759A3 (en) Live attenuated salmonella vaccine
HU0100908D0 (en) Chicken anaemia viruses of low pathogenicity
NZ243251A (en) Vaccine against marek's disease virus in poultry
Cochran Attenuated, genetically-engineered pseudorabies virus S-PRV-155 and uses thereof
YU38503A (sh) Postupci i vakcine za pružanje zaštite in ovo protiv ćurećeg rinotraheitisa